Kathryn Gray, M.D., Ph.D. As a physician-scientist with fellowship training in maternal-fetal medicine and clinical genetics, Dr. Gray is interested in using multi-omic approaches to understand the pathophysiology of adverse obstetric outcomes, in particular preeclampsia and postpartum hemorrhage. She is currently working to establish a preeclampsia consortium with both maternal and fetal samples and has partnered with Genes for Good to collect data on those who have developed preeclampsia during pregnancy.
Shruthi Mahalingaiah, M.D., M.S. has extensive experience researching topics in human reproduction, environmental exposures, and women's health. Her current research focuses on polycystic ovary syndrome (PCOS), and we have partnered with her on our Women's Health and PCOS surveys . Dr. Mahalingaiah is the principal investigator on the OM Study, and we are collecting the same measures in the Genes for Good cohort.